Used as a key intermediate in the synthesis of biologically active compounds, particularly in pharmaceuticals targeting central nervous system disorders. Its structure supports the development of novel psychoactive drugs and cognitive enhancers due to the presence of the fluoromethyl group, which improves metabolic stability and blood-brain barrier penetration. Also employed in the preparation of peptide mimetics and enzyme inhibitors, where the piperazinone core contributes to binding affinity and selectivity. Commonly found in research settings for drug discovery and optimization of neuropharmaceutical agents.